tradingkey.logo
tradingkey.logo
Search

Salarius Pharmaceuticals Ord Shs

DCOY
Add to Watchlist
0.975USD
-0.080-7.58%
Close 11-13 16:00(ET)
2.33MMarket Cap
LossP/E TTM

DCOY Analyst Recommendation Trends

In the current month, DCOY has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. DCOY average Analyst price target in the last month is 3.000.

2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
Strong Buy
1
1
0
0
0
0
0
0
Buy
0
0
0
0
0
0
0
0
Hold
0
0
0
0
0
0
0
0
Strong Sell
0
0
0
0
0
0
0
0
Sell
0
0
0
0
0
0
0
0
Total
1
1
0
0
0
0
0
0

Financial Forecasting

Based on analysts' estimates, DCOY EPS is projected to reach -1.110 in FY2026Q4, following reported EPS of -3.534 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.

EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2024Q3
FY2026Q4
FY2027Q1
Forecast
--
--
-2.59
-432.00
-1.11
-2.16
Actual
-602.19
-4.46
-3.53
--
--
--
Surprise
--
--
-36.45%
--
--
--

FAQs

How have Salarius Pharmaceuticals Ord ShsDCOY's recent earnings per share performed?

The market expectation was USD -3.53, while Salarius Pharmaceuticals Ord ShsDCOY's earnings per share (EPS) for the previous quarter was USD -4.46. EPS for the next quarter is expected at USD -2.16.

What is the analyst rating for Salarius Pharmaceuticals Ord Shs?

Based on the ratings of Salarius Pharmaceuticals Ord Shs's stock from 1 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.